down arrow

Ind-Swift Labs.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE915B01019
  • NSEID: INDSWFTLAB
  • BSEID: 532305
INR
84.36
1.96 (2.38%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 1.01 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Divi's Lab.
Medico Remedies
Cipla
Sun Pharma.Inds.
Jenburkt Pharma
Torrent Pharma
Albert David
Mankind Pharma
Ind-Swift Labs.
Zim Laboratories
Accent Microcell
Why is Ind-Swift Laboratories Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.81 times
  • The company has been able to generate a Return on Equity (avg) of 5.41% signifying low profitability per unit of shareholders funds
2
With a fall in Net Sales of -96.99%, the company declared Very Negative results in Dec 24
  • The company has declared negative results for the last 3 consecutive quarters
  • PAT(HY) At Rs 0.42 cr has Grown at -96.43%
  • PBT LESS OI(Q) At Rs -14.89 cr has Fallen at -187.18%
  • NET SALES(Q) Lowest at Rs 8.66 cr
3
Stock is technically in a Bearish range
  • The technical trend has deteriorated from Mildly Bearish on 07-Mar-25 and has generated -15.69% returns since then
  • Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ind-Swift Labs. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ind-Swift Labs.
-32.98%
-0.61
53.83%
SENSEX
0.45%
0.03
14.48%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-10.46%
EBIT Growth (5y)
-3.25%
EBIT to Interest (avg)
0.56
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.35
Tax Ratio
27.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
3.92%
ROCE (avg)
38.92%
ROE (avg)
5.41%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
7
Industry P/E
33
Price to Book Value
0.52
EV to EBIT
2.64
EV to EBITDA
1.77
EV to Capital Employed
0.14
EV to Sales
0.16
PEG Ratio
1.07
Dividend Yield
NA
ROCE (Latest)
15.49%
ROE (Latest)
10.04%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-32What is not working for the Company
PAT(HY)

At Rs 0.42 cr has Grown at -96.43%

PBT LESS OI(Q)

At Rs -14.89 cr has Fallen at -187.18%

NET SALES(Q)

Lowest at Rs 8.66 cr

PBDIT(Q)

Lowest at Rs -14.53 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at -167.78%

EPS(Q)

Lowest at Rs 0.00

Loading Valuation Snapshot...
Here's what is not working for Ind-Swift Labs.
Profit After Tax (PAT) - Half Yearly
At Rs 0.42 cr has Grown at -96.43%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 8.66 cr has Fallen at -96.99%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -14.89 cr has Fallen at -187.18%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 8.66 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs -14.53 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at -167.78%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -14.89 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.00
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."